BFM
ANGO icon

Boothbay Fund Management’s AngioDynamics ANGO Stock Holding History

Boothbay Fund Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,952
Closed -$85.2K – 1476
2024
Q3 		$85.2K Buy
10,952
+719
+7% +$5.19K ﹤0.01% 1469
2024
Q2 		$61.9K Buy
+10,233
New +$63.1K ﹤0.01% 1394
2024
Q1 		– Sell
-24,086
Closed -$189K – 1563
2023
Q4 		$189K Buy
24,086
+8,119
+51% +$56.3K ﹤0.01% 1345
2023
Q3 		$117K Buy
+15,967
New +$133K ﹤0.01% 1534
2023
Q2 		– Sell
-13,142
Closed -$136K – 1785
2023
Q1 		$136K Buy
+13,142
New +$168K ﹤0.01% 1851
2017
Q1 		– Sell
-13,794
Closed -$233 – 727
2016
Q4 		$233 Buy
+13,794
New +$230K 0.05% 531

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boothbay Fund Management's ANGO Position: Q4 2024 in Review

Boothbay Fund Management sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 10,952 shares — an estimated $85.2K sold.

Boothbay Fund Management first reported a position in ANGO in Q4 2016 and held it in 6 quarters. The position peaked at $189K in Q4 2023. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Boothbay Fund Management reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 10,952 AngioDynamics shares in Q4 2024, an estimated $85.2K.
  • Boothbay Fund Management first reported a position in AngioDynamics in Q4 2016 and held it in 6 quarters.
  • Boothbay Fund Management's AngioDynamics position peaked at $189K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Boothbay Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.